Fox Chase Cancer Center Welcomes Dr. Peter Abdelmessieh

Peter Abdelmessieh, DO, MSc, joins the Department of Bone Marrow Transplant and Cellular Therapies
Peter Abdelmessieh, DO, MSc, joins the Department of Bone Marrow Transplant and Cellular Therapies

PHILADELPHIA (June 30, 2021) – Fox Chase Cancer Center is pleased to announce the hiring of Peter Abdelmessieh, DO, MSc, who will join the Department of Bone Marrow Transplant and Cellular Therapies.

Prior to joining Fox Chase, Abdelmessieh was at Christiana Care Health System in Delaware since August 2018, where he performed a majority of the allogenic stem cell transplants. He was also the first to perform chimeric antigen receptor cell therapy, also known as CAR T, in the state of Delaware.

He did his internal medicine residency at Lenox Hill Hospital in New York City from 2011 to 2014, then moved to Pennsylvania for a hematology and oncology fellowship at Lankenau Medical Center. From 2017 to 2018 he completed a bone marrow transplant fellowship at Weill Cornell/New York Presbyterian Hospital in New York City.

Prior to attending medical school at the Touro College of Osteopathic Medicine in New York, Abdelmessieh received his masters of biomedical science from the University of Medicine and Dentistry of New Jersey and his bachelors of arts and sciences from Cornell University.

Abdelmessieh began work at the center on June 28, 2021.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427

Resize Text